4-NITRO-1-{[4-(TRIFLUOROMETHYL)PHENYL]METHYL-1H-PYRAZOLE, 95.0%, 1g

Ácido succínico, mínimo 99 %, pa, ACS, 250 g, envase de plástico.

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-tert-butyl-L-tyrosine>98.0%(T)(HPLC)5g

(4-Amino-phenyl)-methyl-carbamic acid tert-butyl ester, 95.0%, 1g

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine, 98%, 1g

(S)-2-Amino-2-(3,4-dimethoxyphenyl)acetic acid, 95%, 500mg

3-Fluoro-4-methoxyacetophenone, 98.0%, 5g

(R)-2,2,2-TRIFLUORO-1-(PYRIDIN-2-YL)ETHANAMINE DIHYDROCHLORIDE, 97.0%, 1g

(((7-Bromoheptyl)oxy)methyl)benzene, 98%, 1g

2-(1-isopropylpiperidin-2-yl)ethanamine, 95.0%, 25g

5-Chloropyrazolo[1,5-a]pyrimidin-7(1H)-one, 95.0%, 250mg

tert-Butyl (4-hydroxy-1-methylcyclohexyl)carbamate, 95.0%, 1g

Poly(4-hydroxy-2,2,6,6-tetramethyl-1-piperidineethanol-alt-1,4-butanedioic acid), 95.0%, 250g